MRC Holland is a Dutch biotechnology company renowned for developing innovative molecular diagnostic technologies for copy number variation (CNV) and methylation analysis. The company is best known for its proprietary MLPA® (Multiplex Ligation-dependent Probe Amplification) technology, recognized worldwide as a gold standard for DNA copy number determination. MRC Holland solutions are widely used in clinical genetics, oncology, hereditary disease testing and molecular research laboratories globally.
MRC Holland
Country exclusion: NO
Visit websiteCatalogue
Open PDF